kabutan

AFC-HD AMS Life Science, Net Income Forecast for the Fiscal Year Revised Upward by 6%, Highest in Five Terms

Tue Apr 14, 2026 3:30 pm JST Earnings

2927 AFC-HD AMS Life Science Co.,Ltd. 【J-GAAP】

Earnings Report

AFC-HD AMS Life Science Co.,Ltd. <2927> [TSE Std] announced its financial results after the market closed on April 14th (15:30). The consolidated net income for the cumulative second quarter of the fiscal year ending August 2026 (September 2025 to February 2026) decreased 9.1% from the same period last year to 0.80 billion yen, resulting in a decrease in profits compared to the previous forecast of a 0.2% increase.

However, the full-year forecast for consolidated net income has been revised upward 5.7%, from the previous forecast of 1.46 billion yen to 1.54 billion yen (compared to 1.44 billion yen in the previous period), increasing the growth rate from 1.0% to 6.7%, reaches new record high for the first time in five terms.

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated net income for the March to August period (second half) is expected to expand 31.2% from the same period last year, reaching 0.74 billion yen.

In the most recent three-month period, from December to February (2Q), the consolidated net income dropped to 0.27 billion yen, a 33.7% decrease compared to the same period last year. The operating profit margin worsened from 7.6% in the same period last year to 5.8%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Sep - Feb, 2023 14,542 1,023 1,060 641 45.8 55.2 Apr 15, 2024 J-GAAP
Sep - Feb, 2024 16,614 1,294 1,332 881 62.7 54.5 Apr 14, 2025 J-GAAP
Sep - Feb, 2025 16,846 1,251 1,194 801 55.8 48.8 Apr 14, 2026 J-GAAP
YoY +1.4% -3.3% -10.4% -9.1% -11.0%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep - Feb, 2025 Guidance 16,725 1,297 1,334 883 61.3 18 Oct 15, 2025 J-GAAP
Sep - Feb, 2025 Results 16,846 1,251 1,194 801 55.8 18 Apr 14, 2026 J-GAAP
Revision Rate +0.7% -3.5% -10.5% -9.3% -9.0%

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2026 Prev 34,137 2,545 2,445 1,462 101.1 36 Oct 15, 2025 J-GAAP
Aug, 2026 New 34,137 2,545 2,445 1,545 106.9 36 Apr 14, 2026 J-GAAP
Revision Rate 0.0% 0.0% 0.0% +5.7% +5.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar - Aug, 2025 16,041 1,115 1,111 567 40.3 18 Oct 15, 2025 J-GAAP
Mar - Aug, 2026 Guidance 17,291 1,294 1,251 744 51.5 18 Apr 14, 2026 J-GAAP
YoY +7.8% +16.1% +12.6% +31.2% +27.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 30,185 1,916 1,921 1,252 89.2 30 Oct 15, 2024 J-GAAP
Aug, 2025 32,655 2,409 2,443 1,448 103.0 34 Oct 15, 2025 J-GAAP
Aug, 2026 Guidance 34,137 2,545 2,445 1,545 106.9 36 Apr 14, 2026 J-GAAP
YoY +4.5% +5.6% +0.1% +6.7% +3.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Dec - Feb, 2024 8,425 644 628 421 29.9 7.6 Apr 14, 2025 J-GAAP
Mar - May, 2025 8,123 559 536 531 37.8 6.9 Jul 10, 2025 J-GAAP
Jun - Aug, 2025 7,918 556 575 36 2.6 7.0 Oct 15, 2025 J-GAAP
Sep - Nov, 2025 8,547 771 739 522 36.7 9.0 Jan 14, 2026 J-GAAP
Dec - Feb, 2025 8,299 480 455 279 19.4 5.8 Apr 14, 2026 J-GAAP
YoY -1.5% -25.5% -27.5% -33.7% -35.1%

Related Articles